<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107-molecules-26-00632">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Varghese</surname>
    <given-names>F.S.</given-names>
   </name>
   <name>
    <surname>van Woudenbergh</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Overheul</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Eleveld</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Kurver</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>van Heerbeek</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>van Laarhoven</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Miesen</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>den Hartog</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>de Jonge</surname>
    <given-names>M.I.</given-names>
   </name>
  </person-group>
  <article-title>Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro</article-title>
  <source>bioRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.12.23.424189</pub-id>
 </element-citation>
</ref>
